Strategic partnerships Evidence of active collaboration with major telecom and capital partners (Telefónica, Columna Capital) signals openness to co-development and funding opportunities. Use this to pitch joint ventures, data space collaborations, and funded trial initiatives with pharma clients.

Data collaboration Announcement of Nefro Data Space and data-centric clinical infrastructures indicates a strong capability in data management, analytics, and real-world data integration. Target pharmaceutical sponsors seeking advanced data spaces, trial optimization, and regulatory-grade data solutions.

Global full value Position as a Full Value CRO with global reach plus strategic insights and technology leverage. Sell end-to-end solutions that reduce trial timelines, optimize costs, and improve regulatory success for mid-sized to large sponsors seeking comprehensive outsourcing partners.

Financial traction Mid-market revenue range with growing partnerships suggests upside potential and room for scalable services. Approach account-based selling for expanding pharmas and regional players looking to scale clinical operations and CRO partnerships.

Tech-enabled ops Adoption of modern tech stack and data-focused platforms indicates efficiency and security strengths. Propose converting partners to tech-enabled engagement models, including data sharing, streamlined trial execution, and compliance-driven workflows.